Department of Nuclear Medicine, Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping St, Jiangyang District, Luzhou, Sichuan, China.
School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China.
Mol Imaging Biol. 2023 Dec;25(6):1125-1134. doi: 10.1007/s11307-023-01844-3. Epub 2023 Aug 14.
Heart failure (HF) remains a major cause of late morbidity and mortality after myocardial infarction (MI). To date, no clinically established F-labeled sympathetic nerve PET tracers for monitoring myocardial infarction are available. Therefore, in this study, we synthesized a series of F-labeled benzyl guanidine analogs and evaluated their efficacy as cardiac neuronal norepinephrine transporter (NET) tracers for myocardial imaging. We also investigated the preliminary diagnostic capabilities of these tracers in myocardial infarction animal models, as well as the structure-activity relationship of these tracers.
Three benzyl guanidine-NET tracers, including [F]1, [F]2, and [F]3, were synthesized and evaluated in vivo as PET tracers in a myocardial infarction mouse model. [F]LMI1195 was used as a positive control for the tracers. H&E staining of the isolated myocardial infarction heart tissue sections was performed to verify the efficacy of the selected PET tracer.
Our data show that [F]3 had a moderate decay corrected labeling yield (~10%) and high radiochemical purity (>95%) compared to other tracers. The uptake of [F]3 in normal mouse hearts was 1.7±0.1%ID/cc at 1 h post-injection (p. i.), while it was 2.4±0.1, 2.6±0.9, and 2.1±0.4%ID/cc in the MI mouse hearts at 1, 2, and 3 days after surgery, respectively. Compared with [F]LMI1195, [F]3 had a better myocardial imaging effect in terms of the contrast between normal and MI hearts. The area of myocardial infarction shown by PET imaging corresponded well with the infarcted tissue demonstrated by H&E staining.
With an obvious cardiac uptake contrast between normal mice and the myocardial infarction mouse model, [F]3 appears to be a potential tool in the diagnosis of myocardial infarction. Therefore, it is necessary to conduct further structural modification studies on the chemical structure of [F]3 to improve its in vivo stability and diagnostic detection ability to achieve reliable and practical imaging effects.
心力衰竭(HF)仍然是心肌梗死后晚期发病率和死亡率的主要原因。迄今为止,尚无临床可用的 F 标记的用于监测心肌梗死的交感神经 PET 示踪剂。因此,在这项研究中,我们合成了一系列 F 标记的苄基胍类似物,并评估了它们作为心肌成像中心脏神经元去甲肾上腺素转运体(NET)示踪剂的功效。我们还研究了这些示踪剂在心肌梗死动物模型中的初步诊断能力,以及这些示踪剂的结构-活性关系。
合成了三种苄基胍-NET 示踪剂,包括[F]1、[F]2 和[F]3,并在心肌梗死小鼠模型中作为 PET 示踪剂进行了体内评估。[F]LMI1195 被用作示踪剂的阳性对照。对分离的心肌梗死心脏组织切片进行 H&E 染色,以验证所选 PET 示踪剂的功效。
与其他示踪剂相比,[F]3 的放射性标记产率(~10%)适中,放射化学纯度(>95%)高。[F]3 在正常小鼠心脏中的摄取在注射后 1 小时为 1.7±0.1%ID/cc,而在手术后 1、2 和 3 天的 MI 小鼠心脏中分别为 2.4±0.1、2.6±0.9 和 2.1±0.4%ID/cc。与[F]LMI1195 相比,[F]3 在正常和 MI 心脏之间的心肌成像效果方面具有更好的对比效果。PET 成像显示的心肌梗死面积与 H&E 染色显示的梗死组织吻合良好。
[F]3 在正常小鼠和心肌梗死小鼠模型之间具有明显的心脏摄取对比,因此似乎是诊断心肌梗死的潜在工具。因此,有必要对[F]3 的化学结构进行进一步的结构修饰研究,以提高其体内稳定性和诊断检测能力,从而实现可靠和实用的成像效果。